Navigation Links
PRA International Hosts an Infectious Diseases Audio Conference
Date:12/9/2009

RALEIGH, N.C., Dec. 9 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces its Scientific Head of Infectious Diseases Carl Kraus, M.D., Vice President of Scientific Affairs will host an audio conference along with John Powers, M.D., Assistant Professor of Medicine at George Washington University, on the design and regulatory environment considerations in anti-infective drug development.

Understanding the current regulatory environment and how it will affect the study design in anti-infective drug development is critical to addressing the present concerns of disease due to drug-resistant pathogens, biothreat agents, and novel influenza strains. The need to develop drugs with acceptable risk-benefit profiles for emerging and re-emerging diseases is evident. During the presentation, Drs. Kraus and Powers will review some of the basic principles surrounding anti-infective drug development in the framework of regulatory submissions as well as provide an update on some of the most important changes in recent years related to specific anti-infective indications. A question and answer discussion on selected infectious disease indications will follow their talk.

Both Drs. Powers and Kraus were formerly with the US Food and Drug Administration. At the FDA, Dr. Powers was the lead medical officer for Antimicrobial Drug Development and Resistance Initiatives, and Dr. Kraus was a medical officer in the Division of Special Pathogens and Immunologic Drug Products. Over the years, Dr. Powers has been involved in more than 50 clinical trials as a clinical investigator, has won several teaching awards, and has published extensively in the infectious disease field. Dr. Kraus has participated in more than 20 developmental programs for antiviral, antibiotic and biothreat agents and currently heads the Infectious Diseases Research Center (IDRC) at PRA.

PRA's IDRC is a cross-functional department comprised of staff from Scientific Affairs, Project Management, Patient Recruitment, and Clinical Informatics. The IDRC serves as a central collection point for infectious disease knowledge and provides cross-functional oversight of ongoing studies. Operating globally in Africa, South America, Asia-Pacific, Europe and the United States, IDRC experts offer PRA's clients significant expertise in the design and management of both individual protocols and complete clinical development programs.

The audio conference is scheduled for 16 December 2009 from 11:30 a.m. - 1:00 p.m. (ET). For additional information and to register, please navigate to www.praintl.com and click on "Events" under the News and Events heading.

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in infectious diseases, oncology, neurosciences, respiratory/allergy and cardiovascular. PRA has supported over 2,100 clinical trials through its 36 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
2. Reportlinker Adds Chiral Technology - International Technology & Market Trends
3. Swissray International Announces New Ownership
4. Chindex International to Present at Piper Jaffray Health Care Conference
5. SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts
6. International Operation Combats Online Supply of Counterfeit and Illegal Medicines
7. Lexington International, LLC Receives 2009 U.S. Presidents E Award Recognizing its Export Achievements
8. Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair
9. 2009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name
10. DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
11. Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... 2017   ZappRx, Inc ., a digital health company ... today announced it closed $25 million in Series B funding ... based in Seattle that is part ... The Series B round included participation from SR One ... GV (formerly Google Ventures). As part of the ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
Breaking Medicine Technology:
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to ... rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive open ... resume and wondering if it’s as ready as you are for a new job ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... named the 2017 North American CAREGiverSM of the Year for her extraordinary compassion ... one of its 60,000 North American professional caregivers for the prestigious award each ...
(Date:4/27/2017)... ... 27, 2017 , ... Offering the purest product of its kind, Swissx Labs ... more potent than the market has seen before. Swissx uses proprietary strains of hemp ... patented chromatography process for extraction, to produce its CBD oil--maximizing its benefits for health ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump Technologies, Inc., ... announced it has completed a round of funding to accelerate its growth strategies. ... Black Granite Capital is a growth equity firm focused on investments in healthcare ...
(Date:4/26/2017)... , ... April 26, 2017 ... ... is thrilled to announce the ATA 2017 President’s Awards recipients, comprised of ... demonstrated superior healthcare delivery. , The ATA 2017 President’s Awards recognize ...
Breaking Medicine News(10 mins):